Efficacy of olopatadine hydrochloride 0.1 emedastine difumarate 0.05 and loteprednol etabonate 0.5 for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study

摘要

BackgroundAllergic conjunctivitis (AC) is a disease of various agents that affects the physical and mental health of children. Although the most effective therapy has not been found so far, it is essential to explore the considerable therapeutic method. We compared the clinical efficacy of olopatadine, emedastine, loteprednol etabonate (LE), and vehicle for treating seasonal allergic conjunctivitis (SAC) in Chinese children.